NVDA
NVIDIA Corporation
NVDA's fundamentals are strong and it looks cheap: trading at 21x earnings, about a third of its usual 65x. Analysts expect strong earnings growth.
SNAL
Snail, Inc. Class A Common Stock
There isn't enough reported data to score SNAL yet.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
SNAL Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Healthy | |
| Strong |
SNAL's revenue, profitability, cash flow and balance sheet are all currently healthy.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA has the edge over SNAL in the historical PE scenario, which offers more potential upside but is not a forecast.
SNAL PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 4.4x | $2.28 | — |
| Cheap | 17x | $9.02 | +296% |
| Fair | 22x | $11.59 | +408% |
| Expensive | 32x | $16.62 | +629% |
Historical ranges are pointers, not guarantees.
SNAL's PE is 4.4x, but its earnings don't support one, so it isn't a reliable read right now.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
SNAL Forward outlook
There aren't enough analyst estimates for SNAL to show an outlook.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over SNAL on earnings, with more consistent year-over-year improvement.
SNAL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $0.52 | +$3.92 |
| Q2 2026 | -$1.28 | +$1.04 |
| Q1 2026 | -$3.12 | -1742% |
| Q4 2025 | -$3.70 | -1580% |
| Q3 2025 | -$3.40 | -910% |
| Q2 2025 | -$2.32 | -$2.11 |
| Q1 2025 | $0.19 | +$1.26 |
| Q4 2024 | $0.25 | +$1.48 |
SNAL has returned to profit: it earned $0.52 per share over the past year, after losing money the year before.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over SNAL on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over SNAL on profitability, with a higher operating margin.
SNAL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $33.1M | +139% |
| Q2 2026 | $19.7M | -11% |
| Q1 2026 | $27.3M | +36% |
| Q4 2025 | $25.1M | -4.2% |
| Q3 2025 | $13.8M | -39% |
| Q2 2025 | $22.2M | +2.7% |
| Q1 2025 | $20.1M | +42% |
| Q4 2024 | $26.2M | -8.2% |
SNAL's revenue is growing: $33M last quarter, up 139% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 22% | +91 points |
| Q2 2026 | -14% | -5.3 points |
| Q1 2026 | 7.7% | +28 points |
| Q4 2025 | -6% | -18 points |
| Q3 2025 | -69% | -71 points |
| Q2 2025 | -8.2% | -21 points |
| Q1 2025 | -20% | -4.8 points |
| Q4 2024 | 12% | -1.3 points |
SNAL's operating margin was 22% last quarter, up 91 points from the same quarter a year ago.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over SNAL on cash flow, with more consistent year-over-year improvement.
SNAL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$3.4M | -$175.1K |
| Q1 2026 | $10.2M | +$11.3M |
| Q4 2025 | -$5.3M | -$1.7M |
| Q3 2025 | $5.4M | +$10.4M |
| Q2 2025 | -$3.2M | -1638% |
| Q1 2025 | -$1.1M | -116% |
| Q4 2024 | -$3.6M | -132% |
| Q3 2024 | -$5M | -$3M |
SNAL's free cash flow has turned positive again: $7M over the past year, against −$13M the year before.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has the edge over SNAL on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
SNAL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +5.2% | +441K shares |
| 1 year | +19% | +1.5M shares |
| 3 years | +22% | +1.6M shares |
| 5 years | +21% | +1.6M shares |
SNAL has 9M diluted shares, up 19% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA's net debt is less than a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
SNAL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.2x | Net Cash |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | -0.0x | Net Cash |
| Q3 2024 | -0.5x | Net Cash |
| Q2 2024 | -28.0x | Net Cash |
| Q4 2022 | 1.4x | Healthy |
| Q3 2022 | 0.3x | Very low |
| Q2 2022 | 0.8x | Very low |
SNAL has the edge over NVDA on leverage, with a lower net debt burden relative to earnings.
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
SNAL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 42.3 | Neutral |
| Stochastic | 11.7 | Oversold |
SNAL's weekly RSI is 42 (neutral) and its Stochastic is 12 (oversold).
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA is trading at 21x earnings, a 25% discount to the Technology sector's median of 28x.
SNAL PE vs Technology Sector
| Metric | SNAL | Sector median | Relative |
|---|---|---|---|
| PE | 4.4x | 28x | 84% below |
| PE % | 0 | 39 | 39 pts below |
SNAL has the edge over NVDA on valuation relative to its sector.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
SNAL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.23 | 2.2% above |
| 20 week MA | $3.10 | 26% below |
| 50 week MA | $3.42 | 33% below |
| 100 week MA | $4.97 | 54% below |
| 200 week MA | $5.55 | 59% below |
SNAL has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 59% below its 200-week average.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA has the edge over SNAL on returns for 2026, with the stronger performance.
SNAL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $15.0 | $6.50 | -57% |
| 2023 | $6.50 | $6.05 | -6.9% |
| 2024 | $6.05 | $9.35 | +55% |
| 2025 | $9.35 | $4.58 | -51% |
| 2026 YTD | $4.58 | $2.28 | -50% |
SNAL has finished lower in three of the last four years. It's down 50% so far in 2026.